STAB

Statera Biopharma, Inc. Common Stock
STAB

Overview Fund Activity
Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings

29 hedge funds and large institutions have $4.64M invested in Statera Biopharma, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 4 closing their positions.

Holders
29
Holders Change
+6
Holders Change %
+26.09%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
11
Reduced
3
Closed
4
Calls
$1K
Puts
$36K
Net Calls
-$35K
Net Calls Change
-$51K

Top Buyers

1
EVM
1
Eaton Vance Management
Massachusetts
$354K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$474K
3
State Street
3
State Street
Massachusetts
$157K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$300K
5
BlackRock
5
BlackRock
New York
$140K

Top Sellers

1
UBS Group
1
UBS Group
Switzerland
$0
2
TRCT
2
Tower Research Capital (TRC)
New York
$0
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
Cambridge Investment Research Advisors
4
Cambridge Investment Research Advisors
Iowa
$138K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$960K
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
– -$45K -19,470 Closed
TRCT
27
Tower Research Capital (TRC)
New York
– -$32K -13,891 Closed
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
– -$29K -12,619 Closed
1
2